Rapt Therapeutics (RAPT)
(Delayed Data from NSDQ)
$4.00 USD
-0.40 (-9.09%)
Updated May 14, 2024 04:00 PM ET
After-Market: $4.02 +0.02 (0.50%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Earnings News For RAPT
-
RAPT Therapeutics Reports First Quarter 2024 Financial Results
-
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
-
RAPT Therapeutics Reports Third Quarter 2023 Financial Results
-
RAPT Therapeutics Reports Second Quarter 2023 Financial Results
-
RAPT Therapeutics Reports First Quarter 2023 Financial Results
-
RAPT Therapeutics Reports Fourth Quarter And Year End Financial Results
-
Rapt Therapeutics (RAPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Rapt Therapeutics (RAPT) Reports Q3 Loss, Lags Revenue Estimates
-
RAPT Therapeutics Reports Third Quarter 2022 Financial Results
-
Rapt Therapeutics (RAPT) Reports Q2 Loss, Tops Revenue Estimates
-
Rapt Therapeutics (RAPT) Reports Q1 Loss, Tops Revenue Estimates
-
Rapt Therapeutics (RAPT) Reports Q3 Loss, Lags Revenue Estimates
-
Rapt Therapeutics (RAPT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
RAPT THERAPTICS (RAPT) Reports Q2 Loss, Lags Revenue Estimates
-
Analysts Estimate RAPT THERAPTICS (RAPT) to Report a Decline in Earnings: What to Look Out for
-
RAPT THERAPTICS (RAPT) Reports Q1 Loss, Misses Revenue Estimates
-
RAPT THERAPTICS (RAPT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
RAPT THERAPTICS (RAPT) Reports Q4 Loss, Misses Revenue Estimates